Catheter Ablation of Ventricular Tachycardia: Are We Underestimating the Benefit?

Francis E Marchlinski; Fermin C Garcia; Jesus Almendral; Haris M Haqqani

doi:10.1016/j.jacep.2018.01.002

Catheter Ablation of Ventricular Tachycardia: Are We Underestimating the Benefit?

JACC Clin Electrophysiol. 2018 Mar;4(3):383-385. doi: 10.1016/j.jacep.2018.01.002. Epub 2018 Mar 19.

Authors

Francis E Marchlinski¹, Fermin C Garcia², Jesus Almendral³, Haris M Haqqani⁴

Affiliations

¹ Cardiovascular Division, Electrophysiology Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: francis.marchlinski@uphs.upenn.edu.
² Cardiovascular Division, Electrophysiology Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
³ Electrophysiology Laboratory and Arrhythmia Unit, Monteprincipe Hospital, University CEU-San Pablo, Madrid, Spain.
⁴ Faculty of Medicine, University of Queensland, Prince Charles Hospital, Brisbane, Australia.

PMID: 30089565
DOI: 10.1016/j.jacep.2018.01.002

No abstract available

Keywords: VT recurrence; acute complications; antiarrhythmic drugs; catheter ablation; early referral; ischemic cardiomyopathy; mortality; nonischemic cardiomyopathy; ventricular tachycardia.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Arrhythmias, Cardiac
Catheter Ablation*
Humans
Referral and Consultation
Tachycardia, Ventricular*